Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis.

Jae Heon Kim Sung-Ryul Shim Yash Khandwala Francesco Del Giudice Simon John Christoph Soerensen Benjamin I Chung

Published in: The world journal of men's health (2019)

Overall risk of depression after 5-ARI was significantly not high, however its clinical importance needs validation by further studies. These quantitative results could provide useful information for both clinicians and patients.

Keyphrases

systematic review
end stage renal disease
depressive symptoms
newly diagnosed
ejection fraction
chronic kidney disease
sleep quality
healthcare
high resolution
adverse drug
electronic health record